PREPARATION FOR IBOGAINE THERAPY

​​

Cardiovascular Pre-care​​

• Hypertension

Patients should continue to take blood pressure medication that is not centrally acting. If patients are not on any medication, they should seek medical recommendation about a prescription for blood pressure medication. Patients should not demonstrate hypertensive crisis for at least three days prior to treatment.

​

• Hypotension

Ibogaine may lower blood pressure in patients with hypotension and this could lead to serious complications. Check fluid intake and recommend that patient hydrate with at least 1 fl. oz. per kg of body weight throughout the day, more for physically active people. A good indicator of sufficient hydration is light or clear urine.

 

This intake should be with fluids that contain electrolytes such as coconut water, or other electrolyte preparation, and not with plain water or other fluids. If blood pressure does not increase with hydration, patient should be considered a poor candidate, and should seek further medical attention.

 

• Limited Vein Access

If patient has limited vein access, they should be informed about this risk factor and should attempt to follow the following vascular pre-care protocol for at least 10 days, or if possible, until veins become easily accessible.

• Stop all intravenous substance use.

• Take 1 aspirin per day to thin the blood.

• Take 2g oral Vitamin C per day to help with vein repair.

​

​Cleansing/Fasting​

• Patients will be encouraged not to engage in any cleansing regimens, to severely restrict diet or proteins (example: juice fasting, master cleanse), or any other diet that may otherwise deplete physical energy level or electrolytes from the time of application until after discharge.

• Except when appetite is suppressed by ibogaine during treatment, patients will not be encouraged to cleanse or fast. Patients should be advised to eat healthy, whole meals in order to develop strength.

 

Nutrition & Supplementation

• If patients are below the normal or preferred range of potassium and magnesium (Ch. 2), they should be instructed to supplement until normal blood test results can be returned. If results are not lower than normal, then no supplementation should be recommended. Levels higher the preferred range present a similar risk as deficiency.​​

​​​​

SAFETY CONSIDERATIONS

​​​

• SSRI's should be discontinued two weeks prior to ibogaine treatment. The best way to get off SSRI's is Bufo Alvarius therapy.

• Stopping benzodiazepines or alcohol suddenly or within 72 hours prior to treatment may cause seizures during treatment and can be life threatening.

• Using substances such as stimulants, opiates, or others that interact with ibogaine during treatment, or misrepresenting current or previous use of these substances, greatly increases risk of ibogaine potentiating an overdose.

• Malnutrition or dehydration prior to treatment increases risk of complications which can be life threatening.

• If choosing to use of opiates, stimulants, or other substances that interact with ibogaine after treatment, account for the fact that tolerance has been significantly reduced to that of an opiate naïve person. Otherwise, there is an acute risk of overdose.

 

 

IBOGAINE THERAPY CANNOT BE USED IF YOU HAVE ANY OF THE FOLLOWING​

​

• Arythmia

• Active infection, abscess or inaccessible veins

• Asthma

• Cardiac Conditions

• Cancer

• Cerebral Palsy

• Crohns

• Dementia

• Emotional Disorders

• Emphysema

• Epilepsy

• Gastro-Intestinal Disorders

• High Blood Pressure

• History of Stroke

• Irritable bowel syndrome

• Kidney Disease

• Kidney Stones

• Liver Disease

• Lung Disease

• Migraines

• Multiple sclerosis

• Pregnant

• Psychiatric Disorders

• Unmanaged Diabetes

• Vascular Disease